$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Psychomotor-activating effects mediated by dopamine D2 and D3 receptors in the nucleus accumbens

Pharmacology, biochemistry, and behavior, v.67 no.1, 2000년, pp.161 - 168  

Canales, Juan J. (Corresponding author. Instituto de Investigaciones Citó) ,  Iversen, Susan D. (logicas, Fundació)

Abstract AI-Helper 아이콘AI-Helper

AbstractThe contribution made by specific dopamine receptor subtypes to the induction of motor behaviors has not been firmly established. Here, we first characterized the behavioral effects induced by a D2-class receptor agonist, bromocriptine, following injections into the nucleus accumbens (Acb). ...

주제어

참고문헌 (45)

  1. Eur J Pharmacol Acri 281 2 R7 1995 10.1016/0014-2999(95)00411-D Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands 

  2. Eur J Pharmacol Ahlenius 260 177 1994 10.1016/0014-2999(94)90335-2 Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat 

  3. Life Sci Akunne 57 15 1401 1995 10.1016/0024-3205(95)02102-O Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells 

  4. Neuropsychopharmacology Bancroft 18 4 305 1998 10.1016/S0893-133X(97)00162-0 Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study 

  5. Neuropharmacology Bristow 35 3 285 1996 10.1016/0028-3908(96)00179-7 The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat 

  6. Neuropharmacology Bristow 37 6 793 1998 10.1016/S0028-3908(98)00066-5 Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors 

  7. Neuropharmacology Boulay 38 9 1389 1999 10.1016/S0028-3908(99)00064-7 Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of D2/D3 receptor agonists 

  8. Neuropharmacology Boulay 38 4 555 1999 10.1016/S0028-3908(98)00213-5 Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice 

  9. Br J Pharmacol Bowery 119 7 1491 1996 10.1111/j.1476-5381.1996.tb16063.x Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741626 

  10. Eur J Pharmacol Canales 362 2-3 111 1998 10.1016/S0014-2999(98)00752-3 Behavioural topography in the striatum: differential effects of quinpirole and d-amphetamine microinjections 

  11. Synapse Canales 36 297 2000 10.1002/(SICI)1098-2396(20000615)36:4<297::AID-SYN6>3.0.CO;2-M Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors 

  12. Psychopharmacology (Berlin) Clifford 136 3 284 1998 10.1007/s002130050567 Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach 

  13. Eur J Pharmacol Costall 96 3-4 201 1983 10.1016/0014-2999(83)90309-6 The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour 

  14. Neuropharmacology Daly 32 5 509 1993 10.1016/0028-3908(93)90177-5 Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other D-2-like agonists 

  15. Brain Res DeBoer 608 2 198 1993 10.1016/0006-8993(93)91459-6 Differential effect of systemic administration of bromocriptine and l-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats 

  16. Neuroscience Diaz 65 3 731 1995 10.1016/0306-4522(94)00527-C Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain 

  17. Mol Psychiatry Duaux 3 4 333 1998 10.1038/sj.mp.4000409 Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence 

  18. Psychopharmacology (Berlin) Gianutsos 68 2 139 1980 10.1007/BF00432131 Differential behavioral and biochemical effects of four dopaminergic agonists 

  19. Biochem Soc Trans Griffon 24 1 193 1996 10.1042/bst0240193 Functional models for the dopamine D3 receptor 

  20. Psychopharmacology (Berlin) Jackson 90 1 147 1986 10.1007/BF00172888 Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393 

  21. J Neural Transm Jackson 69 1-2 131 1987 10.1007/BF01244104 Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors 

  22. Naunyn-Schmiedeberg's Arch Pharmacol Jackson 351 2 146 1995 10.1007/BF00169328 Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies 

  23. Neuropharmacology Jenkins 25 11 1243 1986 10.1016/0028-3908(86)90142-5 Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats 

  24. Am J Med Genet Jonsson 88 4 352 1999 10.1002/(SICI)1096-8628(19990820)88:4<352::AID-AJMG12>3.0.CO;2-0 Trend for an association between schizophrenia and D3 S1310, a marker in proximity to the dopamine D3 receptor gene 

  25. Ann N Y Acad Sci Joyce 877 595 1999 10.1111/j.1749-6632.1999.tb09291.x D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics 

  26. Neuropharmacology Kiraly 23 5 511 1984 10.1016/0028-3908(84)90023-6 Non-opiate beta-endorphin fragments and dopamine VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats 

  27. Eur J Neurosci Landwehrmeyer 5 145 1993 10.1111/j.1460-9568.1993.tb00480.x Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography 

  28. Neuropsychopharmacology Levant 17 2 67 1997 10.1016/S0893-133X(97)00024-9 In vivo occupancy of D2 dopamine receptors by nafadotride 

  29. Psychopharmacology (Berlin) Manzanedo 143 1 82 1999 10.1007/s002130050922 The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice 

  30. J Pharmacol Exp Ther Millan 275 2 885 1995 Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy 

  31. Neurosci Lett Ogren 85 3 333 1988 10.1016/0304-3940(88)90588-5 D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways 

  32. Paxinos 1986 The rat brain in stereotaxic coordinates 

  33. NeuroReport Sautel 6 2 329 1995 10.1097/00001756-199501000-00026 A functional test identifies dopamine agonists selective for D3 versus D2 receptors 

  34. J Pharmacol Exp Ther Sautel 275 3 1239 1995 Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents 

  35. Curr Opin Neurol Neurosurg Seeman 6 4 602 1993 Dopamine receptor pharmacology 

  36. Int Rev Neurobiol Sibley 35 391 1993 10.1016/S0074-7742(08)60573-5 Molecular neurobiology of dopaminergic receptors 

  37. Arzneimittelforschung Sokoloff 42(I) 2a 224 1992 

  38. Nature Sokoloff 347 146 1990 10.1038/347146a0 Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics 

  39. Trends Pharmacol Sci Sokoloff 16 270 1995 10.1016/S0165-6147(00)89044-6 Novel dopamine receptors half a decade later 

  40. J Neurosci Staley 16 19 6100 1996 10.1523/JNEUROSCI.16-19-06100.1996 Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities 

  41. Psychiatr Genet Thome 9 1 17 1999 10.1097/00041444-199903000-00004 Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating 

  42. Psychopharmacology (Berlin) Ushijima 95 1 34 1988 10.1007/BF00212762 Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning 

  43. Ann N Y Acad Sci Xu 844 27 1998 10.1111/j.1749-6632.1998.tb08219.x Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach 

  44. Synapse Xu 31 3 210 1999 10.1002/(SICI)1098-2396(19990301)31:3<210::AID-SYN6>3.0.CO;2-0 Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists 

  45. Br J Pharmacol Zarrindast 96 4 843 1989 10.1111/j.1476-5381.1989.tb11893.x Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로